EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders

Taku Hatano, Ayami Okuzumi, Gen Matsumoto, Taiji Tsunemi, Nobutaka Hattori

Journal of Movement Disorders · 30.04.2024 · 17 (2) · 127-137

DOI: 10.14802/jmd.24075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Movement Disorders, erschienen am 30.04.2024. Verfasst von Taku Hatano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Scientific Research, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mutations in the SNCA gene, which encodes α-synuclein (α-syn), play a key role in the development of genetic Parkinson’s disease (PD). α-Syn is a major component of Lewy bodies in PD and glial cytoplasmic inclusions in multiple system atrophy (MSA). Rapid eye movement sleep behavior disorder patients often progress to PD, dementia with Lewy bodies, or MSA, which are collectively known as α-synucleinopathies. The loss of dopaminergic neurons with Lewy bodies precedes motor dysfunction in these diseases, but the mechanisms of neurodegeneration due to α-syn aggregation are poorly understood. Monitoring α-syn aggregation in vivo could serve as a diagnostic biomarker and help elucidate pathogenesis, necessitating a simple and accurate detection method. Seed amplification assays (SAAs), such as real-time quaking-induced conversion and protein misfolding cyclic amplification, are used to detect small amounts of abnormally structured α-syn protofibrils, which are central to aggregation. These methods are promising for the early diagnosis of α-synucleinopathy. Differences in α-syn filament structures between α-synucleinopathies, as observed through transmission electron microscopy and cryo-electron microscopy, suggest their role in the pathogenesis of neurodegeneration. SAAs may differentiate between subtypes of α-synucleinopathy and other diseases. Efforts are also being made to identify α-syn from blood using various methods. This review introduces body fluid α-syn biomarkers based on pathogenic α-syn seeds, which are expected to redefine α-synucleinopathy diagnosis and staging, improving clinical research accuracy and facilitating biomarker development.

Schlagwörter

Stichwörter der Autor:innen

Multiple system atrophyParkinson’s diseaseSeed amplification assaysα-Synucleinα-Synucleinopathy

Autor:innen und Institutionen

  • Department of Neurology, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Department of Histology and Cell Biology, Nagasaki University School of Medicine, Nagasaki, Japan.
  • Neurodegenerative Disorders Collaboration Laboratory, RIKEN Center for Brain Science, Saitama, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • Scientific Research
  • Japan Society for the Promotion of Science
  • Visionary Council
  • Research Committee of CNS Degenerative Disease
  • Health, Labor, and Welfare Sciences Research Grants
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Hatano, T., Okuzumi, A., Matsumoto, G., Tsunemi, T., & Hattori, N. (2024). α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders. Journal of Movement Disorders, 17(2), 127-137. https://doi.org/10.14802/jmd.24075

Vancouver

Hatano T, Okuzumi A, Matsumoto G, Tsunemi T, Hattori N. α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders. Journal of Movement Disorders. 2024;17(2):127-137. doi:10.14802/jmd.24075

BibTeX
@article{Hatano2024,
  author = {Hatano, Taku and Okuzumi, Ayami and Matsumoto, Gen and Tsunemi, Taiji and Hattori, Nobutaka},
  title = {α-Synuclein: A Promising Biomarker for Parkinson’s Disease and Related Disorders},
  journal = {Journal of Movement Disorders},
  year = {2024},
  volume = {17},
  number = {2},
  pages = {127--137},
  doi = {10.14802/jmd.24075}
}
Kostenlos starten →